Ido Goldstein
Ido Goldstein
確認したメール アドレス: - ホームページ
‘Cancer associated fibroblasts’–more than meets the eye
S Madar, I Goldstein, V Rotter
Trends in molecular medicine 19 (8), 447-453, 2013
p53‐repressed miRNAs are involved with E2F in a feed‐forward loop promoting proliferation
R Brosh, R Shalgi, A Liran, G Landan, K Korotayev, GH Nguyen, E Enerly, ...
Molecular systems biology 4 (1), 229, 2008
Understanding wild-type and mutant p53 activities in human cancer: new landmarks on the way to targeted therapies
I Goldstein, V Marcel, M Olivier, M Oren, V Rotter, P Hainaut
Cancer gene therapy 18 (1), 2-11, 2011
Steroid receptors reprogram FoxA1 occupancy through dynamic chromatin transitions
EE Swinstead, TB Miranda, V Paakinaho, S Baek, I Goldstein, M Hawkins, ...
Cell 165 (3), 593-605, 2016
TMPRSS2/ERG promotes epithelial to mesenchymal transition through the ZEB1/ZEB2 axis in a prostate cancer model
O Leshem, S Madar, I Kogan-Sakin, I Kamer, I Goldstein, R Brosh, ...
PloS one 6 (7), e21650, 2011
Regulation of lipid metabolism by p53–fighting two villains with one sword
I Goldstein, V Rotter
Trends in Endocrinology & Metabolism 23 (11), 567-575, 2012
Modulated expression of WFDC1 during carcinogenesis and cellular senescence
S Madar, R Brosh, Y Buganim, O Ezra, I Goldstein, H Solomon, I Kogan, ...
Carcinogenesis 30 (1), 20-27, 2009
Mutant p53R273H attenuates the expression of phase 2 detoxifying enzymes and promotes the survival of cells with high levels of reactive oxygen species
E Kalo, I Kogan-Sakin, H Solomon, E Bar-Nathan, M Shay, Y Shetzer, ...
Journal of cell science 125 (22), 5578-5586, 2012
Various p53 mutant proteins differently regulate the Ras circuit to induce a cancer-related gene signature
H Solomon, Y Buganim, I Kogan-Sakin, L Pomeraniec, Y Assia, S Madar, ...
Journal of Cell Science 125 (13), 3144-3152, 2012
p53, a novel regulator of lipid metabolism pathways
I Goldstein, O Ezra, N Rivlin, A Molchadsky, S Madar, N Goldfinger, ...
Journal of hepatology 56 (3), 656-662, 2012
p53 Regulates the Ras circuit to inhibit the expression of a cancer-related gene signature by various molecular pathways
Y Buganim, H Solomon, Y Rais, D Kistner, I Nachmany, M Brait, S Madar, ...
Cancer research 70 (6), 2274-2284, 2010
p53 promotes the expression of gluconeogenesis-related genes and enhances hepatic glucose production
I Goldstein, K Yizhak, S Madar, N Goldfinger, E Ruppin, V Rotter
Cancer & metabolism 1 (1), 1-6, 2013
A novel translocation breakpoint within the BPTF gene is associated with a pre-malignant phenotype
Y Buganim, I Goldstein, D Lipson, M Milyavsky, S Polak-Charcon, ...
PloS one 5 (3), e9657, 2010
The role of the p53 tumor suppressor in metabolism and diabetes
CP Kung, ME Murphy
The Journal of endocrinology 231 (2), R61, 2016
Transcriptional and chromatin regulation during fasting–the genomic era
I Goldstein, GL Hager
Trends in Endocrinology & Metabolism 26 (12), 699-710, 2015
Chemotherapeutic agents induce the expression and activity of their clearing enzyme CYP3A4 by activating p53
I Goldstein, N Rivlin, O Shoshana, O Ezra, S Madar, N Goldfinger, ...
Carcinogenesis 34 (1), 190-198, 2013
Transcriptional activity of ATF3 in the stromal compartment of tumors promotes cancer progression
Y Buganim, S Madar, Y Rais, L Pomeraniec, E Harel, H Solomon, E Kalo, ...
Carcinogenesis 32 (12), 1749-1757, 2011
Bivariate genomic footprinting detects changes in transcription factor activity
S Baek, I Goldstein, GL Hager
Cell reports 19 (8), 1710-1722, 2017
Transcription factor assisted loading and enhancer dynamics dictate the hepatic fasting response
I Goldstein, S Baek, DM Presman, V Paakinaho, EE Swinstead, GL Hager
Genome research 27 (3), 427-439, 2017
The human 1‐8D gene (IFITM2) is a novel p53 independent pro‐apoptotic gene
V Daniel‐Carmi, E Makovitzki‐Avraham, EM Reuven, I Goldstein, N Zilkha, ...
International journal of cancer 125 (12), 2810-2819, 2009
論文 1–20